{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:03:23Z","timestamp":1790730203504,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.nbd.2026.107288","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:34:59Z","timestamp":1770050099000},"page":"107288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Multi-omics dissection of Parkinson\u2019s patients in subgroups associated with motor and cognitive severity"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0091-5986","authenticated-orcid":false,"given":"Efi","family":"Athieniti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiroula","family":"Afxenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Minadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Spyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107288_b1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.parkreldis.2019.10.019","article-title":"Sex differences in Parkinson\u2019s disease presentation and progression","volume":"69","author":"Abraham","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107288_b2","article-title":"Multi-Omics factor analysis - A framework for unsupervised integration of multi-omic data sets","author":"Argelaguet","year":"2017","journal-title":"bioRxiv"},{"key":"10.1016\/j.nbd.2026.107288_b3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.csbj.2022.11.050","article-title":"A guide to multi-omics data collection and integration for translational medicine","volume":"21","author":"Athieniti","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.nbd.2026.107288_b4","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102881","article-title":"Drug repurposing on Alzheimer\u2019s disease through modulation of NRF2 neighborhood","volume":"67","author":"Bourdakou","year":"2023","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41531-021-00228-0","article-title":"Comprehensive subtyping of Parkinson\u2019s disease patients with similarity fusion: a case study with BioFIND data","volume":"7","author":"Brendel","year":"2021","journal-title":"NPJ Parkinson\u2019s Dis."},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b6","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1038\/s41467-023-43053-0","article-title":"Early-to-mid stage idiopathic Parkinson\u2019s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females","volume":"14","author":"Capelle","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.nbd.2026.107288_b7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00401-023-02597-7","article-title":"Transcriptomic profiling of Parkinson\u2019s disease brains reveals disease stage specific gene expression changes","volume":"146","author":"Cappelletti","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107288_b8","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.567537","article-title":"GAP-43 and BASP1 in Axon Regeneration: Implications for the Treatment of Neurodegenerative Diseases","volume":"8","author":"Chung","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.nbd.2026.107288_b9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The Drug Repurposing Hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nature Med."},{"issue":"11","key":"10.1016\/j.nbd.2026.107288_b10","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112495","article-title":"The Endoplasmic Reticulum Stress\/Unfolded Protein Response and Their Contributions to Parkinson\u2019s Disease Physiopathology","volume":"9","author":"Costa","year":"2020","journal-title":"Cells"},{"issue":"August","key":"10.1016\/j.nbd.2026.107288_b11","article-title":"RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson\u2019s disease","volume":"1","author":"Craig","year":"2021","journal-title":"Nat. Aging"},{"issue":"21","key":"10.1016\/j.nbd.2026.107288_b12","doi-asserted-by":"crossref","first-page":"8832","DOI":"10.1039\/D2CS00624C","article-title":"Emerging degrader technologies engaging lysosomal pathways.","volume":"51","author":"Ding","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.nbd.2026.107288_b13","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1073\/pnas.1909110117","article-title":"NK cells clear \u03b1-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of \u03b1-synucleinopathy","volume":"117","author":"Earls","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107288_b14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3389\/fnins.2019.01381","article-title":"Vesicular Dysfunction and the Pathogenesis of Parkinson\u2019s Disease: Clues From Genetic Studies","volume":"13","author":"Ebanks","year":"2019","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2026.107288_b15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0404.1994.tb02699.x","article-title":"Parkinson\u2019s disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood","volume":"90","author":"Fiszer","year":"1994","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b16","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1038\/s41598-020-62678-5","article-title":"Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity","volume":"10","author":"Francelle","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107288_b17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13040-015-0059-z","article-title":"Principal component gene set enrichment (PCGSE)","volume":"8","author":"Frost","year":"2015","journal-title":"BioData Min."},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13024-022-00558-4","article-title":"Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity","volume":"17","author":"Hsieh","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b19","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1038\/s41467-023-39652-6","article-title":"Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson\u2019s disease","volume":"14","author":"Irmady","year":"2023","journal-title":"Nat. Commun."},{"issue":"9996","key":"10.1016\/j.nbd.2026.107288_b20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.nbd.2026.107288_b21","article-title":"Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson\u2019s disease","volume":"3","author":"Karayel","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.nbd.2026.107288_b22","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1212\/WNL.0000000000203217","article-title":"A Phase 2 Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous ANX005 in Patients with, or at Risk of, Manifest Huntington\u2019s Disease (HD) (S32.009)","volume":"100","author":"Kumar","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"10.1016\/j.nbd.2026.107288_b24","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.181321","article-title":"Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining","volume":"5","author":"Liu","year":"2018","journal-title":"R. Soc. Open Sci."},{"issue":"12","key":"10.1016\/j.nbd.2026.107288_b25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","article-title":"Current understanding of the molecular mechanisms in Parkinson\u2019s disease: Targets for potential treatments","volume":"6","author":"Maiti","year":"2017","journal-title":"Transl. Neurodegener."},{"issue":"4","key":"10.1016\/j.nbd.2026.107288_b27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"The Parkinson Progression Marker Initiative (PPMI)","volume":"95","author":"Marek","year":"2011","journal-title":"Prog. Neurobiol."},{"issue":"7","key":"10.1016\/j.nbd.2026.107288_b28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/acschemneuro.2c00019","article-title":"Fibrinogen and Complement Factor H Are Promising CSF Protein Biomarkers for Parkinson\u2019s Disease with Cognitive Impairment A Proteomics ELISA Based Study","volume":"13","author":"Naskar","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2026.107288_b29","article-title":"Identifying the predictive role and the related drugs of oxidative stress genes in the hepatocellular carcinoma","volume":"7","author":"Nie","year":"2024","journal-title":"Cancer Rep."},{"issue":"6","key":"10.1016\/j.nbd.2026.107288_b30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/CS20230513","article-title":"The complement system in neurodegenerative diseases","volume":"138","author":"Nimmo","year":"2024","journal-title":"Clin. Sci. (London, Engl. : 1979)"},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12938-018-0477-5","article-title":"Marine-derived protein kinase inhibitors for neuroinflammatory diseases","volume":"17","author":"Ning","year":"2018","journal-title":"BioMedical Eng. OnLine"},{"issue":"2","key":"10.1016\/j.nbd.2026.107288_b32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/md302064","article-title":"Verrucarin A Inhibition of MAP Kinase Activation in a PMA-stimulated Promyelocytic Leukemia Cell Line","volume":"3","author":"Oda","year":"2005","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.nbd.2026.107288_b33","unstructured":"Pfister S, F.E., Rapid benchmarking of methods for *in silico* deconvolution of bulk RNA-seq data. R package version 1.14.0. R Packag. URL https:\/\/github.com\/xanibas\/granulator."},{"issue":"13","key":"10.1016\/j.nbd.2026.107288_b34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137426","article-title":"Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule","volume":"23","author":"Potenza","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41531-023-00449-5","article-title":"A systematic review and meta-analysis of inflammatory biomarkers in Parkinson\u2019s disease","volume":"9","author":"Qu","year":"2023","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"10.1016\/j.nbd.2026.107288_b36","series-title":"psych: Procedures for Psychological, Psychometric, and Personality Research","author":"Revelle","year":"2024"},{"issue":"7","key":"10.1016\/j.nbd.2026.107288_b37","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2026.107288_b38","series-title":"OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data","author":"R\u00f6st","year":"2014"},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b39","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/s41598-020-59414-4","article-title":"Cerebrospinal fluid proteomics implicates the granin family in Parkinson\u2019s disease","volume":"10","author":"Rotunno","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.nbd.2026.107288_b40","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/hmg\/ddab294","article-title":"Fine-mapping of Parkinson\u2019s disease susceptibility loci identifies putative causal variants","volume":"31","author":"Schilder","year":"2022","journal-title":"Hum. Mol. Gen."},{"issue":"5","key":"10.1016\/j.nbd.2026.107288_b41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41746-024-01175-9","article-title":"Identification of Parkinson\u2019s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data","volume":"7","author":"Su","year":"2024","journal-title":"Npj Digit. Med."},{"issue":"43","key":"10.1016\/j.nbd.2026.107288_b43","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107288_b44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1177932219899051","article-title":"Multi-omics Data Integration, Interpretation, and Its Application","volume":"14","author":"Subramanian","year":"2020","journal-title":"Bioinform. Biol. Insights"},{"issue":"11","key":"10.1016\/j.nbd.2026.107288_b45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41231-024-00169-9","article-title":"Systematic analysis of multi-omics data reveals component-specific blood-based biomarkers for Parkinson\u2019s disease","volume":"9","author":"Tng","year":"2024","journal-title":"Transl. Med. Commun."},{"issue":"12","key":"10.1016\/j.nbd.2026.107288_b47","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1093\/brain\/awad265","article-title":"How should we be using biomarkers in trials of disease modification in Parkinson\u2019s disease?","volume":"146","author":"Vijiaratnam","year":"2023","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.nbd.2026.107288_b48","first-page":"1247","article-title":"Drug Gene Budger (DGB): an application for ranking drugs to modulate a specific gene based on transcriptomic signatures.","volume":"35","author":"Wang","year":"2019","journal-title":"Bioinform. (Oxford, England)"},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2007.08.010","article-title":"Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson\u2019s disease","volume":"425","author":"Waragai","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00702-019-02125-6","article-title":"Predict cognitive decline with clinical markers in Parkinson\u2019s disease (PRECODE-1)","volume":"127","author":"Wilson","year":"2020","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b51","doi-asserted-by":"crossref","first-page":"fcac343","DOI":"10.1093\/braincomms\/fcac343","article-title":"Identification of a possible proteomic biomarker in Parkinson\u2019s disease: discovery and replication in blood, brain and cerebrospinal fluid.","volume":"5","author":"Winchester","year":"2023","journal-title":"Brain Commun."},{"issue":"3","key":"10.1016\/j.nbd.2026.107288_b52","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innov."},{"issue":"2","key":"10.1016\/j.nbd.2026.107288_b53","article-title":"Protocol for analysis of RNA-sequencing and proteome profiling data for subgroup identification and comparison.","volume":"3","author":"Yang","year":"2022","journal-title":"STAR Protoc."},{"issue":"3","key":"10.1016\/j.nbd.2026.107288_b54","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1186\/1471-2164-10-S3-S32","article-title":"PDbase: a database of Parkinson\u2019s Disease-related genes and genetic variation using substantia nigra ESTs","volume":"10","author":"Yang","year":"2009","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.nbd.2026.107288_b55","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41531-023-00572-3","article-title":"Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson\u2019s disease","volume":"9","author":"Yang","year":"2023","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.nbd.2026.107288_b56","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105890","article-title":"Abnormal immune function of B lymphocyte in peripheral blood of Parkinson\u2019s disease","volume":"116","author":"Zhang","year":"2023","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107288_b57","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1040293","article-title":"Subtyping of early-onset Parkinson\u2019s disease using cluster analysis: A large cohort study.","volume":"14","author":"Zhou","year":"2022","journal-title":"Front. Aging Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612600032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612600032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T21:56:31Z","timestamp":1778018191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999612600032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":57,"alternative-id":["S096999612600032X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107288","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omics dissection of Parkinson\u2019s patients in subgroups associated with motor and cognitive severity","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107288"}}